Imaginarium, a leading multi-speciality digital manufacturing business, has announced that the company's customised, bio-compatible 3D printed orthotic device is successfully supporting the recovery ...
Infinx Healthcare to set-up centre of excellence in Madurai to create 700 jobs: Our Bureau, Bengaluru Thursday, November 7, 2024, 16:35 Hrs [IST] Infinx, a trusted provider of AI- ...
Four innovative projects have been awarded a total of £1.8 million in research funding aimed at helping to reduce drug use among young people. This is the second phase of NIHR’s Innovation Fund to ...
Duoning Biotech enters partnership with Branca Bunús to promote the next generation of transfection reagents: Shanghai Thursday, November 7, 2024, 16:00 Hrs [IST] Duoning Biotech ...
Global Health’s Medanta to operate and manage a 750 bed super speciality hospital in Pitampura, New Delhi: Our Bureau, Bengaluru Thursday, November 7, 2024, 14:15 Hrs [IST] Glob ...
NIHR hands multi-million dementia funding to top UK research institute: United Kingdom Thursday, November 7, 2024, 15:00 Hrs [IST] The NIHR has handed multi-million pound funding ...
MicrobioTx unveils fingerprick-based test to profile gut microbiome: Our Bureau, Bengaluru Thursday, November 7, 2024, 14:30 Hrs [IST] MicrobioTx, a new-age gut microbiome company ...
A new World Health Organization (WHO) study published in eBioMedicine names 17 pathogens that regularly cause diseases in communities as top priorities for new vaccine development. The WHO study is ...
Hyderabad-based Neuland Laboratories has registered a decline of 63.4 per cent in net profit at Rs. 32.84 crore on a consolidated basis, during the quarter ended September 30, 2024, as compared to Rs.
Roche announced that it will present more than 40 abstracts across nine blood disorders at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, held 7-10 December 2024 in San ...
EMA approves Dupixent to treat eosinophilic esophagitis in children as young as one year: Paris Thursday, November 7, 2024, 14:00 Hrs [IST] The European Medicines Agency has appro ...
IGI to present first-data from phase I study of cancer drug in ASH annual meeting: Our Bureau, New Delhi Thursday, November 7, 2024, 11:30 Hrs [IST] Ichnos Glenmark Innovation (IG ...